局灶射頻消融治療低危與中危局限性前列腺癌的療效分析
Efficacy of focal radiofrequency ablation in the treatment of low-to-intermediate risk localized prostate cancer
GAO Shu,JIANG Zhen,SUN Jiyuan,HUANG Haifeng,ZHANG Qing,GUO Hongqian
(Department of Urology,Nanjing Drum Tower Hospital,Affiliated Hospital of Medical School,Nanjing University,Nanjing 210000,China)
ABSTRACT:Objective To explore the efficacy of focal radiofrequency ablation (RFA) in the treatment of low-to-intermediate risk localized prostate cancer and its impact on postoperative urinary control and sexual function recovery,in order to explore the feasibility of minimally invasive methods for the treatment of localized prostate cancer.Methods Clinical data of 28 patients with low-to-intermediate risk localized prostate cancer who underwent RFA in Nanjing Drum Tower Hospital,Affiliated Hospital of Medical School during Jun.2017 and Feb.2021 were retrospectively analyzed.The 5-year failure-free survival (FFS) rate,surgery related complications,postoperative urinary control and sexual function were collected.The differences between the survival curves of patients in the low-risk and intermediate-risk subgroups were assessed with log-rank test and Breslow test.Results All surgeries were successfully completed under local anesthesia.During the median follow-up of 43 (40-49) months,the 5-year FFS rate predicted by Kaplan-Meier method was 78.57%; 25 patients (89.29%) did not experience surgery-related complications; 27 patients (96.43%) were able to control urination; 1 patient developed new-onset sexual dysfunction.There was no significant difference in the survival curves between patients in the low-risk and intermediate-risk groups (P>0.05).Conclusion RFA for patients with low-to-intermediate risk localized prostate cancer has good clinical efficacy,little impact on urinary control and sexual function recovery,and few postoperative complications,which can be used as one of the treatment options for these patients.
KEY WORDS:focal radiofrequency ablation; prostate cancer; low-to-intermediate risk; localized; failure-free survival rate;urinary control;sexual function
摘要:目的 探討局灶射頻消融(RFA)治療低危與中危局限性前列腺癌的療效及其對患者術(shù)后尿控和性功能恢復(fù)的影響,以期探究微創(chuàng)方法治療局限性前列腺癌的可行性。(剩余9403字)
-
-
- 現(xiàn)代泌尿外科雜志
- 2025年02期
- 復(fù)雜性泌尿系結(jié)石治療新方法:針...
- 重視前列腺外科包膜鑲嵌增生結(jié)節(jié)...
- 女性壓力性尿失禁的解剖學(xué)發(fā)病機...
- 尿路上皮癌抗體偶聯(lián)藥物臨床應(yīng)用...
- 哮喘與女性夜尿癥的相關(guān)性:20...
- 前列腺穿刺活檢術(shù)術(shù)后感染的危險...
- 機器人腹腔鏡下左側(cè)腎癌合并癌栓...
- 超聲引導(dǎo)輸尿管軟鏡鈥激光內(nèi)切開...
- 機器人輔助改良Y型原位新膀胱術(shù)...
- 局灶射頻消融治療低危與中危局限...
- 斜仰臥-截石位下微小通道經(jīng)皮腎...
- 骶神經(jīng)調(diào)控治療頑固性間質(zhì)性膀胱...
- 低能量沖擊波治療難治性前列腺盆...
- 術(shù)前天冬氨酸轉(zhuǎn)氨酶/丙氨酸轉(zhuǎn)氨...
- Cldn14基因敲除對大鼠草酸...
- 膀胱癌靶向藥物的新載體:金屬納...
- 經(jīng)皮腎鏡腎臟異物取出術(shù)1例報告...
- 膀胱淋巴上皮瘤樣尿路上皮癌1例...